Glass House Brands Produces More Cannabis Than Ever, but Margins Take a Hit
Glass House Brands (NYSE: GLAS) reported $56.8 million in revenue for the third quarter of 2026, more than double the $26.2 million recorded a year earlier, driven by higher cannabis production and wholesale volumes.
The California-based producer reported a net loss of $10.1 million, compared with a $12.2 million loss in the same quarter last year.
However, the company’s sequential results presented a more complicated picture. Revenue increased 21% from the second quarter, while gross margin declined from 34% to 26% and adjusted EBITDA fell from $5.7 million to approximately $779,000.
The results highlight the challenge of converting expanding cannabis production into consistent profitability amid wholesale price fluctuations.
Record Cannabis Production, Lower Selling Prices
Glass House produced approximately 319,000 pounds of cannabis biomass during the quarter, up from 246,000 pounds in Q2 and 124,000 pounds a year earlier.
Wholesale biomass generated $50 million in revenue, accounting for approximately 88% of total quarterly sales.
The company reduced production costs to $109 per pound, compared with $122 in Q2 and $128 a year earlier.
However, the average selling price declined to $151 per pound from $211 in the previous quarter, a decrease of approximately 28%.
The lower pricing, combined with a greater proportion of trim in the sales mix, contributed to the decline in gross margin.
Glass House reported gross profit of $14.6 million, down from $15.8 million in Q2 despite higher revenue.
Adjusted EBITDA Declines as Expenses Increase
Adjusted EBITDA reached approximately $779,000, compared with $5.7 million in the second quarter and a loss of $2.3 million in Q3 2025.
The company attributed the sequential decline partly to higher professional expenses tied to its New York Stock Exchange listing and Sarbanes-Oxley compliance work, along with lower gross profit.
General and administrative expenses increased to $16.2 million from $13.4 million in Q2, while professional fees rose to $3.2 million from $1.6 million.
Operating cash flow was negative $149,000, compared with positive $179,000 in the previous quarter and negative $5.1 million a year earlier.
Cash Position Improves Following Capital Raises
Glass House ended September with $39.7 million in cash, cash equivalents and restricted cash, compared with $22.1 million at the end of June.
The company raised approximately $18 million through its at-the-market equity offering program during the quarter and reported another $10 million in warrant proceeds.
These financing activities helped increase the company’s cash balance while it continued investing in production capacity.
Capital expenditures totaled $5.4 million during the quarter, primarily related to expansion at its Camarillo greenhouse operations.
The company also made approximately $2.9 million in preferred shareholder distributions.
Glass House Maintains Production Outlook
Glass House reaffirmed its forecast of approximately 1 million pounds of wholesale cannabis biomass production for 2026.
Management also maintained its longer-term production cost target of $95 per pound.
CEO Kyle Kazan said the company continues working to improve production efficiency while preparing for potential interstate and international medical cannabis commerce.
Glass House recently obtained Good Agricultural and Collection Practices certifications for its Casitas and Padaro farms, part of its preparations for possible international supply arrangements.
However, those opportunities remain dependent on applicable regulatory approvals and commercial agreements.
The company’s near-term financial performance will depend on whether lower production costs can offset wholesale price fluctuations and whether increased output translates into stronger margins and operating cash flow.
The relationship between cannabis production economics, access to capital and federal regulatory developments will also be part of the conversation at IgniteIt’s Cannabis Capital & Policy Summit in Washington, D.C., on November 18, bringing together executives, investors and policymakers to discuss the industry’s financial and regulatory outlook.

